Skip to content
TASI: 2222Energy

Saudi Aramco

Saudi Arabian Oil Company
My lists →
Change company
EDITABLE, SOURCE-LINKED MODEL

Operating cash-flow DCF

Projects cash flow from operating earnings after royalties. The starting margin removes the reported PRefChem sale gain. September cash, investments, borrowings and minority interests convert operating value to shareholder value.

Valuation dateModel basis date
Earnings basis & source figures

Uses FY2025 plus 9M 2026 minus 9M 2025. Starting operating income excludes the SAR 25,902m PRefChem disposal gain and retains reported impairment. Earlier operating results include activity before the sale, so the model is a trailing benchmark. The bridge uses the September 30 balance sheet after the sale.

Review figures and sources ↓

Values are per share. Lower and higher growth keep your other edits and change initial growth within the funding limit. Starting assumptions resets the model assumptions.

12 MONTHS TO SEPTEMBER 2026

Reported cash flow and investment

Cash-flow statement ↗
Operating cash flow509.0SAR bn
Capital expenditure184.4SAR bn
Operating cash less capex324.6SAR bn

Figures use FY2025 + 9M 2026 − 9M 2025. The model estimates future cash flow from operating margin, tax and reinvestment.

What changed in the September model
  • The model removes the SAR 25.9bn PRefChem disposal gain from the starting margin. Trailing earnings still include operations before the sale. Disposal note ↗
  • The starting earnings retain SAR 25.4bn of trailing impairment and remeasurement losses.
  • The HUMAIN contribution and Q3 dividend declaration followed the model date. Filing notes ↗
Stress one assumptionSelect to apply the change to your current inputs.
SCENARIO VALUE / SHARE19.47 SAR

At the reporting date—not a live price target or recommendation.

TERMINAL SHARE OF VALUE48.42%Stress-test long-term assumptions below
30 Sept 2036FORECASTRevenue incl. sales-related income2.53T SARFree cash flow to firm452.78B SAR
Revenue incl. sales-related incomeMODEL FORECAST01T2T3TSept 26Sept 27Sept 29Sept 30Sept 31Sept 32Sept 34Sept 35Sept 36
30 Sept 2026 — 30 Sept 2036Revenue incl. sales-related income · 31.16%Free cash flow to firm · —
Compare periods
Hover or tap to exploreSAR

TTM TO SEP 2026 · The first point is the editable model anchor (derived from the selected earnings basis); hatched bars are forecasts. Hover, tap or use arrow keys to inspect. Drag across periods to compare. Projected cash flows are not announced distributions.

From cash flows to share value · SAR millions

PV of forecast cash flows2,540,973.01
PV of terminal value2,385,758.1
Cash + investments (editable proxies)367,661
Debt + minority claims-582,840
Other adjustments0
Common equity value4,711,552.11
Shares, millions242,000
02

Valuation sensitivity

Select a cell to apply its discount rate and terminal growth together.

SAR per share · discount rate × terminal growth
Discount / growth1.50%2.00%2.50%3.00%3.50%
9.00%
9.50%
10.00%
10.50%
11.00%
ONE ASSUMPTION AT A TIME

What does the price imply?

Enter a reference price and date to see which assumption would match it with all other inputs held fixed.

Price supplied by you
Implied assumption · Revenue growth—

Add a positive price and its date to calculate the result.

Current model input
3%
Solver range
-49.99% – 50%

Value per share by assumption

Revenue growth
7%ASSUMPTIONModel value21.3815 SAR
Valuation by assumption0510152025-1%0%1%2%3%4%5%6%7%
Hover or tap to exploreSAR

Bars show scenarios around your current assumption.

03

Year-by-year forecast

SAR millions. Reinvestment funds growth; it is not an additional operating expense.

Year endingNOPATReinvestmentCash flowDiscount factorPresent value
2027-09-30446,266.0564,990.2381,275.850.9091346,614.41
2028-09-30459,406.1168,756.11390,6500.8264322,851.24
2029-09-30472,677.8472,832.68399,845.160.7513300,409.59
2030-09-30486,070.3877,264.65408,805.730.6830279,219.81
2031-09-30499,572.3382,106.48417,465.850.6209259,213.45
2032-09-30513,171.887,425.16425,746.640.5645240,322.88
2033-09-30526,856.3893,303.96433,552.420.5132222,480.94
2034-09-30540,613.1999,847.78440,765.410.4665205,620.31
2035-09-30554,428.86107,190.55447,238.310.4241189,672.7
2036-09-30568,289.58115,506.01452,783.570.3855174,567.67
Formulas & reconciliation

Revenueₜ = Revenueₜ₋₁ × (1 + growthₜ). NOPATₜ = Revenueₜ × margin × (1 − tax). Reinvestmentₜ = (NOPATₜ − NOPATₜ₋₁) ÷ ROICₜ. FCFFₜ = NOPATₜ − reinvestmentₜ.

PVₜ = cash flowₜ ÷ (1 + discount rate)ᵗ. Terminal value = terminal cash flow ÷ (discount rate − terminal growth). PV of terminal = terminal value ÷ (1 + discount rate)ᴺ.

Terminal cash = NOPATᴺ × (1 + g) − (NOPATᴺ × g ÷ terminal ROIC). Share value = (PV of FCFF + PV of terminal + cash + investments − debt − minority claims + other adjustments) ÷ shares.

↗

Analyst estimates

Published outlooks and past results

Single research firm

Forward analyst estimates

Aljazira Capital · Source date

Open source ↗
2026E2.08T SAR
RevenueBROKER ESTIMATE2026E
FY2026E
2,078,000

Values in SAR millions. This snapshot reflects the date shown. DCF assumptions are set separately.

04

Every number, with its source

Reported inputs below are converted to SAR millions where needed. Page references are PDF page numbers.

TTM revenue and sales-related income1,932,1671,671,204 + 1,515,877 − 1,254,914
TTM operating income as reported815,800706,822 + 660,951 − 551,973
Starting operating income after disposal gain adjustment789,898815,800 − 25,902
Starting operating margin (%)40.881789,898 ÷ 1,932,167 × 100
Reported tax and zakat proxy (%)45.149368,082 ÷ 815,263 × 100
Investments at carrying value224,14378,165 + 42,354 + 89,780 + 13,844
Borrowings including leases360,010310,601 + 49,409
TTM operating cash less capital expenditure324,639508,996 − 184,357
Reported inputPeriodValueUnitSource
Revenue and other income related to salesFY20251,671,204SAR mPage 14 ↗
Revenue and other income related to sales9M 20261,515,877SAR mPage 27 ↗
Revenue and other income related to sales9M 2025 comparative1,254,914SAR mPage 27 ↗
Operating incomeFY2025706,822SAR mPage 14 ↗
Operating income9M 2026660,951SAR mPage 27 ↗
Operating income9M 2025 comparative551,973SAR mPage 27 ↗
Income taxes and zakat expenseFY2025352,650SAR mPage 14 ↗
Income taxes and zakat expense9M 2026282,811SAR mPage 27 ↗
Income taxes and zakat expense9M 2025 comparative267,379SAR mPage 27 ↗
Income before income taxes and zakatFY2025702,860SAR mPage 14 ↗
Income before income taxes and zakat9M 2026663,362SAR mPage 27 ↗
Income before income taxes and zakat9M 2025 comparative550,959SAR mPage 27 ↗
PRefChem disposal gainThe gain includes derecognized net liabilities and additional receivables. It is removed once from the starting operating margin.9M 202625,902SAR mPage 42 ↗
Impairment and held-for-sale remeasurement lossesFY202532,425SAR mPage 14 ↗
Impairment and held-for-sale remeasurement losses9M 20261,908SAR mPage 27 ↗
Impairment and held-for-sale remeasurement losses9M 2025 comparative8,886SAR mPage 27 ↗
Cash and cash equivalents30 Sep 2026143,518SAR mPage 29 ↗
Joint ventures and associates30 Sep 202678,165SAR mPage 29 ↗
Non-current securities30 Sep 202642,354SAR mPage 29 ↗
Current securities30 Sep 202689,780SAR mPage 29 ↗
Short-term investments30 Sep 202613,844SAR mPage 29 ↗
Non-current borrowings30 Sep 2026310,601SAR mPage 29 ↗
Current borrowings30 Sep 202649,409SAR mPage 29 ↗
Lease liabilities included in borrowingsIncluded in the borrowing total.30 Sep 202658,282SAR mPage 38 ↗
Non-controlling interests30 Sep 2026222,830SAR mPage 29 ↗
Issued ordinary shares including treasuryFY2025242,000m sharesPage 19 ↗
Operating cash flowFY2025510,798SAR mPage 18 ↗
Operating cash flow9M 2026355,835SAR mPage 31 ↗
Operating cash flow9M 2025 comparative357,637SAR mPage 31 ↗
Capital expenditureFY2025190,444SAR mPage 18 ↗
Capital expenditure9M 2026134,211SAR mPage 31 ↗
Capital expenditure9M 2025 comparative140,298SAR mPage 31 ↗
Post-period HUMAIN cash contributionThe acquisition closed after the September model date. September cash and investments are the bridge inputs.1 Nov 20269,892SAR mPage 43 ↗
Post-period base dividend declaredThe filing states this dividend will be deducted in the fourth quarter. This is the board declaration date.2 Nov 202682,068SAR mPage 43 ↗
Edit the enterprise-to-equity bridge

The source facts above never change. These are model overrides only. Enter an additional present-value cost as negative or asset as positive; it applies once, without changing recurring profit or book growth. Do not deduct an already recorded provision, liability or approved dividend again.